Aadi Bioscience, Inc.
Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug candidate, FYARRO is a form of sirolimu…
Biotechnology
US, Pacific Palisades [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
Aadi Bioscience, Inc. can't present it's sankey chart.
Historical Revenue By Segment
Last 3Y, in million USDAadi Bioscience, Inc. can't present revenue by segment